Ad
related to: modafinil other names for children with dementia treatment centers in ohiogoodrx.com has been visited by 100K+ users in the past month
Search results
Results from the WOW.Com Content Network
A Cephalon-founded study in which patients were administered modafinil, methylphenidate, and a placebo found that modafinil produces "psychoactive and euphoric effects and feelings consistent with [methylphenidate]." [12] Like modafinil, armodafinil is an inhibitor and/or inducer of certain cytochrome P450 enzymes.
Flmodafinil (developmental code names CRL-40,940, NLS-4, JBG01-41), also known as bisfluoromodafinil and lauflumide, is a wakefulness-promoting agent related to modafinil which has been developed for treatment of a variety of different medical conditions.
[3] [2] [4] The modafinil analogues are of interest in the potential treatment of a condition involving the misuse of stimulant drugs (psychostimulant use disorder or PSUD), as drugs that help increase motivation (pro-motivational agents) to treat motivational disorders, [4] [5] [6] and for treatment of neurodegenerative diseases such as ...
Eugeroics, in the sense of modafinil-type wakefulness promoting agents, include modafinil itself, armodafinil, and adrafinil, among others. [9] They are medically indicated for the treatment of certain sleep disorders , including excessive daytime sleepiness (EDS) in narcolepsy or obstructive sleep apnea (OSA).
Modafinil does not improve mood or motivation in sleep-deprived or non-sleep deprived individuals. [ 20 ] Methylphenidate – a benzylpiperidine derivative that may improve working memory , episodic memory , and inhibitory control , aspects of attention , and planning latency in healthy people.
Modafinil has been studied in the treatment of major depressive disorder. [242] [243] [244] In a 2021 systematic review and meta-analysis of randomized controlled trials of psychostimulants for depression, modafinil and other stimulants such as methylphenidate and amphetamines improved depression in traditional meta-analysis. [244]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
RDS03-94, or RDS3-094, is an atypical dopamine reuptake inhibitor that was derived from the wakefulness-promoting agent modafinil. [1] [2] [3] [4]It has substantially higher affinity and potency in terms of dopamine transporter (DAT) inhibition than modafinil (K i = 39.4 nM vs. 8,160 nM) whilst retaining the atypical DAT blocker profile of modafinil.
Ad
related to: modafinil other names for children with dementia treatment centers in ohiogoodrx.com has been visited by 100K+ users in the past month